0001209191-18-063787.txt : 20181220
0001209191-18-063787.hdr.sgml : 20181220
20181220211412
ACCESSION NUMBER: 0001209191-18-063787
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181219
FILED AS OF DATE: 20181220
DATE AS OF CHANGE: 20181220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mokari Atabak
CENTRAL INDEX KEY: 0001678419
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 181247431
MAIL ADDRESS:
STREET 1: 1212 TERRA BELLA AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-19
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001678419
Mokari Atabak
C/O BELLICUM PHARMACEUTICALS, INC.
2130 W. HOLCOMBE BLVD., STE. 800
HOUSTON
TX
77030
0
1
0
0
Sr. VP and CFO
Stock Option (right to buy)
3.42
2018-12-19
4
A
0
300000
0.00
A
2028-12-18
Common Stock
300000
300000
D
25% of the shares subject to the stock option vest and become exercisable on December 19, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
/s/ Shane M. Ward, Attorney-in-Fact
2018-12-20